Skip to main content

united-therapeutics-logo

United Therapeutics Corp. said it has received Food and Drug Administration approval for an implantable pump for Remodulin, its flagship pulmonary arterial hypertension drug.

{iframe}https://www.bizjournals.com/washington/news/2018/07/31/united-therapeutics-gets-crucial-green-light-for.html?ana=e_me_set1&s=newsletter&ed=2018-08-01&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1533562594&j=83024331{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.